Literature DB >> 1545324

Assessing distress in pediatric intensive care environments: the COMFORT scale.

B Ambuel1, K W Hamlett, C M Marx, J L Blumer.   

Abstract

Managing psychological distress is a central treatment goal in Pediatric Intensive Care Units (PICUs), with medical and psychological implications. However, there is no objective measure for assessing efficacy of pharmacologic and psychological interventions used to reduce distress. Development of the COMFORT scale is described, a nonintrusive measure for assessing distress in PICU patients. Eight dimensions were selected based upon a literature review and survey of PICU nurses. Interrater agreement and internal consistency were high. Criterion validity, assessed by comparison with concurrent global ratings of PICU nurses, was also high. Principal components analysis revealed 2 correlated factors, behavioral and physiologic, accounting for 84% of variance. An ecological-developmental model is presented for further study of children's distress and coping in the PICU.

Entities:  

Mesh:

Year:  1992        PMID: 1545324     DOI: 10.1093/jpepsy/17.1.95

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  90 in total

Review 1.  Assessment and management of pain in neonates.

Authors:  B J Stevens; L S Franck
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  What about pain in disorders of consciousness?

Authors:  C Schnakers; C Chatelle; A Demertzi; S Majerus; S Laureys
Journal:  AAPS J       Date:  2012-04-18       Impact factor: 4.009

3.  Assessing pain in ventilated newborns and infants: validation of the Hartwig score.

Authors:  Christoph Hünseler; Verena Merkt; Mandy Gerloff; Frank Eifinger; Angela Kribs; Bernhard Roth
Journal:  Eur J Pediatr       Date:  2010-12-01       Impact factor: 3.183

4.  Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models.

Authors:  Massimo Cella; Catherijne Knibbe; Saskia N de Wildt; Joop Van Gerven; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

5.  Integrative Review of Gut Microbiota and Expression of Symptoms Associated With Neonatal Abstinence Syndrome.

Authors:  Stephanie D Sealschott; Rita H Pickler; Christine A Fortney; Michael T Bailey
Journal:  Nurs Res       Date:  2020 Sep/Oct       Impact factor: 2.381

6.  Behavioral Observation of Infants With Life-Threatening or Life-Limiting Illness in the Neonatal Intensive Care Unit.

Authors:  Christine A Fortney; Stephanie D Sealschott; Rita H Pickler
Journal:  Nurs Res       Date:  2020 Sep/Oct       Impact factor: 2.381

7.  Introduction of Ultra-High-Field MR Imaging in Infants: Preparations and Feasibility.

Authors:  K V Annink; N E van der Aa; J Dudink; T Alderliesten; F Groenendaal; M Lequin; F E Jansen; K S Rhebergen; P Luijten; J Hendrikse; H J M Hoogduin; E R Huijing; E Versteeg; F Visser; A J E Raaijmakers; E C Wiegers; D W J Klomp; J P Wijnen; M J N L Benders
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

8.  A multidimensional approach to pain assessment in critically ill infants during a painful procedure.

Authors:  Manon Ranger; C Celeste Johnston; Janet E Rennick; Catherine Limperopoulos; Thomas Heldt; Adré J du Plessis
Journal:  Clin J Pain       Date:  2013-07       Impact factor: 3.442

9.  A comparison of gradual sedation levels using the Comfort-B scale and bispectral index in children on mechanical ventilation in the pediatric intensive care unit.

Authors:  Cláudia da Costa Silva; Marta Maria Osório Alves; Michel Georges dos Santos El Halal; Sabrina dos Santos Pinheiro; Paulo Roberto Antonacci Carvalho
Journal:  Rev Bras Ter Intensiva       Date:  2013 Oct-Dec

10.  Morphine versus remifentanil for intubating preterm neonates.

Authors:  Yerkes Pereira e Silva; Renato Santiago Gomez; Juliana de Oliveira Marcatto; Thadeu Alves Maximo; Rosilu Ferreira Barbosa; Ana Cristina Simões e Silva
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-10-30       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.